Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (57)
Jules C. Hancox, Mark J. McPate, Aziza El Harchi, Andrew S. Butler, Yihong Zhang, Dominic G. Whittaker, Christopher E. Dempsey, Harry J. Witchel, Ismail Adeniran, Alan G. Stuart & Henggui Zhang. 2023. Heart Rate and Rhythm. Heart Rate and Rhythm
517
538
.
Fjodor Melnikov, Lennart T. Anger & Catrin Hasselgren. (2022) Toward Quantitative Models in Safety Assessment: A Case Study to Show Impact of Dose–Response Inference on hERG Inhibition Models. International Journal of Molecular Sciences 24:1, pages 635.
Crossref
Crossref
Jillian A. Parker, Ernest S. Fung, Alejandra Trejo-Martin, Lisa Liang, Katherine Gibbs, Suren Bandara, Stephanie Chen, Reena Sandhu, Joel Bercu & Andrew Maier. (2022) The utility of hERG channel inhibition data in the derivation of occupational exposure limits. Regulatory Toxicology and Pharmacology 134, pages 105224.
Crossref
Crossref
Mengyi Shan, Chen Jiang, Lu‐Ping Qin & Gang Cheng. (2022) A Review of Computational Methods in Predicting hERG Channel Blockers. ChemistrySelect 7:31.
Crossref
Crossref
Weizhe Ding, Yang Nan, Juanshu Wu, Chenyang Han, Xiangxin Xin, Siyuan Li, Hongsheng Liu & Li Zhang. (2022) Combining multi-dimensional molecular fingerprints to predict the hERG cardiotoxicity of compounds. Computers in Biology and Medicine 144, pages 105390.
Crossref
Crossref
N.S. Hari Narayana Moorthy, Chandrabose Karthikeyan & Elangovan Manivannan. (2021) Multi-algorithm based machine learning and structural pattern studies for hERG ion channel blockers mediated cardiotoxicity prediction. Chemometrics and Intelligent Laboratory Systems 208, pages 104213.
Crossref
Crossref
Vishal B. Siramshetty, Dac-Trung Nguyen, Natalia J. Martinez, Noel T. Southall, Anton Simeonov & Alexey V. Zakharov. (2020) Critical Assessment of Artificial Intelligence Methods for Prediction of hERG Channel Inhibition in the “Big Data” Era. Journal of Chemical Information and Modeling 60:12, pages 6007-6019.
Crossref
Crossref
Miao Liu, Li Zhang, Shimeng Li, Tianzhou Yang, Lili Liu, Jian Zhao & Hongsheng Liu. (2020) Prediction of hERG potassium channel blockage using ensemble learning methods and molecular fingerprints. Toxicology Letters 332, pages 88-96.
Crossref
Crossref
Hyunho Kim & Hojung Nam. (2020) hERG-Att: Self-attention-based deep neural network for predicting hERG blockers. Computational Biology and Chemistry 87, pages 107286.
Crossref
Crossref
Chuipu Cai, Pengfei Guo, Yadi Zhou, Jingwei Zhou, Qi Wang, Fengxue Zhang, Jiansong Fang & Feixiong Cheng. (2019) Deep Learning-Based Prediction of Drug-Induced Cardiotoxicity. Journal of Chemical Information and Modeling 59:3, pages 1073-1084.
Crossref
Crossref
Surovi Saikia, Manobjyoti Bordoloi, Rajeev Sarmah & Bhaskor Kolita. (2019) Antiviral compound screening, peptide designing, and protein network construction of influenza a virus (strain a/Puerto Rico/8/1934 H1N1). Drug Development Research 80:1, pages 106-124.
Crossref
Crossref
Soren Wacker & Sergei Yu. Noskov. (2018) Performance of machine learning algorithms for qualitative and quantitative prediction drug blockade of hERG1 channel. Computational Toxicology 6, pages 55-63.
Crossref
Crossref
Shibu Marthandam Asokan, Ravichandran Mariappan, Shanmugavadivu Muthusamy & Bharath Kumar Velmurugan. (2018) Pharmacological benefits of neferine - A comprehensive review. Life Sciences 199, pages 60-70.
Crossref
Crossref
Zhi-Zhong Liu, Jia-Wei Huang, Yong Wang & Dong-Sheng Cao. (2018) ECoFFeS: A Software Using Evolutionary Computation for Feature Selection in Drug Discovery. IEEE Access 6, pages 20950-20963.
Crossref
Crossref
Moza M. Al‐Owais, Nishani T. Hettiarachchi, Hannah M. Kirton, Matthew E. Hardy, John P. Boyle, Jason L. Scragg, Derek S. Steele & Chris Peers. (2017)
A key role for peroxynitrite‐mediated inhibition of cardiac ERG (Kv11.1) K
+
channels in carbon monoxide–induced proarrhythmic early afterdepolarizations
. The FASEB Journal 31:11, pages 4845-4854.
Crossref
Crossref
Alexandre V. Ivachtchenko, Ilya Okun, Vladimir Aladinskiy, Yan Ivanenkov, Angela Koryakova, Ruben Karapetyan, Oleg Mitkin, Ramiz Salimov & Andrey Ivashchenko. (2017) AVN-492, A Novel Highly Selective 5-HT6R Antagonist: Preclinical Evaluation. Journal of Alzheimer's Disease 58:4, pages 1043-1063.
Crossref
Crossref
Karen Ocorr, Alexander Zambon, Yoav Nudell, Santiago Pineda, Soda Diop, Min Tang, Takeshi Akasaka & Erika Taylor. (2017) Age-dependent electrical and morphological remodeling of the Drosophila heart caused by hERG/seizure mutations. PLOS Genetics 13:5, pages e1006786.
Crossref
Crossref
Verena Gotta, Zhiyi Yu, Frank Cools, Karel Ammel, David J. Gallacher, Sandra A. G. Visser, Frederick Sannajust, Pierre Morissette, Meindert Danhof & Piet H. Graaf. (2016)
Application of a systems pharmacology model for translational prediction of
hERG
‐mediated
QT
c prolongation
. Pharmacology Research & Perspectives 4:6.
Crossref
Crossref
Shuangquan Wang, Huiyong Sun, Hui Liu, Dan Li, Youyong Li & Tingjun Hou. (2016) ADMET Evaluation in Drug Discovery. 16. Predicting hERG Blockers by Combining Multiple Pharmacophores and Machine Learning Approaches. Molecular Pharmaceutics 13:8, pages 2855-2866.
Crossref
Crossref
Sun Hongmao. 2016. A Practical Guide to Rational Drug Design. A Practical Guide to Rational Drug Design
225
268
.
Bruno O. Villoutreix & Olivier Taboureau. (2015) Computational investigations of hERG channel blockers: New insights and current predictive models. Advanced Drug Delivery Reviews 86, pages 72-82.
Crossref
Crossref
Kumiko Fujii, Yuji Ozeki, Hiroaki Okayasu, Yumiko Takano, Takahiro Shinozaki, Hiroaki Hori, Masami Orui, Minoru Horie, Hiroshi Kunugi & Kazutaka Shimoda. (2014) QT Is Longer in Drug-Free Patients with Schizophrenia Compared with Age-Matched Healthy Subjects. PLoS ONE 9:6, pages e98555.
Crossref
Crossref
Rong Wang, Zhenzhen Liu, Lupei Du & Minyong Li. (2014) Design, synthesis and biological evaluation of 4-chromanone derivatives as IKr inhibitors. Drug Discoveries & Therapeutics 8:2, pages 76-83.
Crossref
Crossref
Ki-Wug Sung & Sang June Hahn. (2013) Effect of mosapride on Kv4.3 potassium channels expressed in CHO cells. Naunyn-Schmiedeberg's Archives of Pharmacology 386:10, pages 905-916.
Crossref
Crossref
Hongmao Sun, Menghang Xia, Sampada A. Shahane, Ajit Jadhav, Christopher P. Austin & Ruili Huang. (2013) Are hERG channel blockers also phospholipidosis inducers?. Bioorganic & Medicinal Chemistry Letters 23:16, pages 4587-4590.
Crossref
Crossref
Myoung Joo Park, Kyeong-Ryoon Lee, Dae-Seop Shin, Hang-Suk Chun, Cheol-Hee Kim, Sung-Hoon Ahn & Myung Ae Bae. (2013) Predicted drug-induced bradycardia related cardio toxicity using a zebrafish in vivo model is highly correlated with results from in vitro tests. Toxicology Letters 216:1, pages 9-15.
Crossref
Crossref
Rashmi R. Shah & Ihor Gussak. 2013. Electrical Diseases of the Heart. Electrical Diseases of the Heart
73
122
.
C. Ian SpencerNianzhen LiQin ChenJuliette JohnsonTanner NevillJuha KammonenCristian Ionescu-Zanetti. (2012) Ion Channel Pharmacology Under Flow: Automation Via Well-Plate Microfluidics. ASSAY and Drug Development Technologies 10:4, pages 313-324.
Crossref
Crossref
David A. Köpfer, Ulrike Hahn, Iris Ohmert, Gert Vriend, Olaf Pongs, Bert L. de Groot & Ulrich Zachariae. (2012) A Molecular Switch Driving Inactivation in the Cardiac K+ Channel hERG. PLoS ONE 7:7, pages e41023.
Crossref
Crossref
Mi-Hyeong Park, Won Sun Park & Su-Hyun Jo. (2012) Acute alteration of cardiac ECG, action potential, IKr and the human ether-a-go-go-related gene (hERG) K+ channel by PCB 126 and PCB 77. Toxicology and Applied Pharmacology 262:1, pages 60-69.
Crossref
Crossref
Sichao Wang, Youyong Li, Junmei Wang, Lei Chen, Liling Zhang, Huidong Yu & Tingjun Hou. (2012) ADMET Evaluation in Drug Discovery. 12. Development of Binary Classification Models for Prediction of hERG Potassium Channel Blockage. Molecular Pharmaceutics 9:4, pages 996-1010.
Crossref
Crossref
Harry J. Witchel. (2011) Drug-induced hERG Block and Long QT Syndrome. Cardiovascular Therapeutics 29:4, pages 251-259.
Crossref
Crossref
Seong Jun Park, Helmut Buschmann & Carsten Bolm. (2011) Bioactive sulfoximines: Syntheses and properties of Vioxx® analogs. Bioorganic & Medicinal Chemistry Letters 21:16, pages 4888-4890.
Crossref
Crossref
Jules C. Hancox, Mark J. McPate, Aziza El Harchi, Rona S. Duncan, Chris E. Dempsey, Harry J. Witchel, Ismail Adeniran & Henggui Zhang. 2011. Heart Rate and Rhythm. Heart Rate and Rhythm
431
449
.
Alistair Mathie. (2010) Ion channels as novel therapeutic targets in the treatment of pain. Journal of Pharmacy and Pharmacology 62:9, pages 1089-1095.
Crossref
Crossref
FADI G. AKAR. (2010) Use‐Dependent Modulation of Myocardial Conduction by a New Class of HERG Agonists: Deal Breaker or Cherry on Top?. Journal of Cardiovascular Electrophysiology 21:8, pages 930-932.
Crossref
Crossref
Ivone Un San Leong, Jonathan R. Skinner, Andrew N. Shelling & Donald R. Love. (2010) Identification and expression analysis of kcnh2 genes in the zebrafish. Biochemical and Biophysical Research Communications 396:4, pages 817-824.
Crossref
Crossref
Attila S. Farkas & Stanley Nattel. (2010) Minimizing Repolarization-Related Proarrhythmic Risk in Drug Development and Clinical Practice. Drugs 70:5, pages 573-603.
Crossref
Crossref
George Thomas, Brian Klatt & Andrew Blight. (2010) Effect of 4‐Aminopyridine on Action Potential Parameters in Isolated Dog Purkinje Fibers. Archives of Drug Information 3:1, pages 19-25.
Crossref
Crossref
Rong-Hui Du, Hong-Wei Yi, De-Zai Dai, Wei-Hua Tang & Yin Dai. (2008) Inflammatory factors that contribute to upregulation of ERG and cardiac arrhythmias are suppressed by CPU86017, a class III antiarrhythmic agent. Journal of Pharmacy and Pharmacology 60:8, pages 1089-1095.
Crossref
Crossref
Reza Tabrizchi. 2010. Adverse Drug Reactions. Adverse Drug Reactions
77
109
.
Armando Lagrutta & Joseph J. Salata. 2009. Novel Therapeutic Targets for Antiarrhythmic Drugs. Novel Therapeutic Targets for Antiarrhythmic Drugs
233
269
.
Guohui Cui, Wenxiu Shu, Qing Wu & Yan Chen. (2009) Effect of Gambogic acid on the regulation of hERG channel in K562 cells in vitro. Journal of Huazhong University of Science and Technology [Medical Sciences] 29:5, pages 540-545.
Crossref
Crossref
Muthukrishnan Renganathan, Serguei Sidach & Andrew R. Blight. (2009) Effects of 4-Aminopyridine on Cloned hERG Channels Expressed in Mammalian Cells. Archives of Drug Information 2:3, pages 51-57.
Crossref
Crossref
Dimitri Mikhailov, Martin Traebert, Qiang Lu, Steven Whitebread & William Egan. 2009. Hit and Lead Profiling. Hit and Lead Profiling
387
413
.
Khac-Minh Thai & Gerhard F. Ecker. (2009) Similarity-based SIBAR descriptors for classification of chemically diverse hERG blockers. Molecular Diversity 13:3, pages 321-336.
Crossref
Crossref
Ulrich ZachariaeFabrizio Giordanetto & Andrew G. Leach. (2009) Side Chain Flexibilities in the Human Ether-a-go-go Related Gene Potassium Channel (hERG) Together with Matched-Pair Binding Studies Suggest a New Binding Mode for Channel Blockers. Journal of Medicinal Chemistry 52:14, pages 4266-4276.
Crossref
Crossref
Steven B. Karch. 2009. TASER® Conducted Electrical Weapons: Physiology, Pathology, and Law. TASER® Conducted Electrical Weapons: Physiology, Pathology, and Law
315
325
.
M J McPate, R S Duncan, J C Hancox & H J Witchel. (2008)
Pharmacology of the short QT syndrome N588K-hERG K
+
channel mutation: differential impact on selected class I and class III antiarrhythmic drugs
. British Journal of Pharmacology 155:6, pages 957-966.
Crossref
Crossref
Khac-Minh Thai & Gerhard F. Ecker. (2008) Classification Models for hERG Inhibitors by Counter-Propagation Neural Networks. Chemical Biology & Drug Design 72:4, pages 279-289.
Crossref
Crossref
Jules C. Hancox, Mark J. McPate, Aziza El Harchi & Yi hong Zhang. (2008) The hERG potassium channel and hERG screening for drug-induced torsades de pointes. Pharmacology & Therapeutics 119:2, pages 118-132.
Crossref
Crossref
Rashmi R. Shah. (2008) If a drug deemed ‘safe’ in nonclinical tests subsequently prolongs QT in phase 1 studies, how can its sponsor convince regulators to allow development to proceed?. Pharmacology & Therapeutics 119:2, pages 215-221.
Crossref
Crossref
Lei Jia & Hongmao Sun. (2008) Support vector machines classification of hERG liabilities based on atom types. Bioorganic & Medicinal Chemistry 16:11, pages 6252-6260.
Crossref
Crossref
Earl Gordon, Irina M. Lozinskaya, Zuojun Lin, Simon F. Semus, Frank E. Blaney, Robert N. Willette & Xiaoping Xu. (2008)
2-[2-(3,4-Dichloro-phenyl)-2,3-dihydro-1
H
-isoindol-5-ylamino]-nicotinic Acid (PD-307243) Causes Instantaneous Current through Human
Ether-a-go-go
-Related Gene Potassium Channels
. Molecular Pharmacology 73:3, pages 639-651.
Crossref
Crossref
Sarah Dalibalta & John S. Mitcheson. 2008. Antitargets. Antitargets
89
108
.
Fabrizio De Ponti. 2008. Antitargets. Antitargets
53
88
.
Jie Zhao, Xiao-Li Wei, Yong-Sheng Jia & Jian-Quan Zheng. (2008) Silencing of herg gene by shRNA inhibits SH-SY5Y cell growth in vitro and in vivo. European Journal of Pharmacology 579:1-3, pages 50-57.
Crossref
Crossref